The prevalence of migraine in women of childbearing age is high, estimated at 24%. Migraine management during pregnancy and lactation can be challenging. Our understanding of the way in which medications affect the unborn fetus is still incomplete and the evidence is constantly changing with more recent emphasis on longitudinal studies and childhood development. The aim of this article is to describe the relationship between migraine and pregnancy and review the current evidence on treatment options in pregnancy and lactation.
LiptonRBBigalMEDiamondMet al.
Migraine prevalence, disease burden, and the need for preventive therapy. Neurology2007;
68: 343–349.
2.
Headache Classification Committee of the International Headache S.
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia2013;
33: 629–808.
3.
AfridiSKGiffinNJKaubeHet al.
A positron emission tomographic study in spontaneous migraine. Arch Neurol2005;
62: 1270–1275.
4.
MayA.Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging. Neurol Sci2017;
38: 125–130.
5.
AkermanSHollandPRGoadsbyPJ.Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci2011;
12: 570–584.
GranellaFSancesGZanferrariCet al.
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache1993;
33: 385–389.
8.
MelhadoEMMacielJAJrGuerreiroCA.Headache during gestation: evaluation of 1101 women. Can J Neurol Sci2007;
34: 187–192.
9.
SancesGGranellaFNappiREet al.
Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia2003;
23: 197–205.
10.
MacGregorEA.Oestrogen and attacks of migraine with and without aura. Lancet Neurol2004;
3: 354–361.
11.
MarcusDAScharffLTurkD.Longitudinal prospective study of headache during pregnancy and postpartum. Headache1999;
39: 625–632.
12.
AdeneyKLWilliamsMAMillerRSet al.
Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med2005;
18: 167–172.
13.
ChenHMChenSFChenYHet al.
Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia2010;
30: 433–438.
14.
FacchinettiFAllaisGNappiREet al.
Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia2009;
29: 286–292.
15.
BushnellCDJamisonMJamesAH.Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ2009;
338: b664.
16.
WabnitzABushnellC.Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. Cephalalgia2015;
35: 132–139.
17.
BanhidyFAcsNHorvath-PuhoEet al.
Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res Part A Clin Mol Teratol2006;
76: 592–601.
18.
PenzienDBIrbyMBSmithermanTAet al.
Well-established and empirically supported behavioral treatments for migraine. Curr Pain Headache Rep2015;
19: 34.
19.
LiewZRitzBRebordosaCet al.
Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr2014;
168: 313–320.
LiDKLiuLOdouliR.Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ2003;
327: 368.
22.
DanielSKorenGLunenfeldEet al.
Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions. CMAJ2014;
186: E177–E182.
23.
Nezvalova-HenriksenKSpigsetONordengH.Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG2013;
120: 948–959.
24.
Nezvalova-HenriksenKSpigsetONordengH.Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache2010;
50: 563–575.
25.
KallenBNilssonEOtterblad OP.Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. DrugSaf2011;
34: 691–703.
26.
MarchenkoAEtwelFOlutunfeseOet al.
Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache2015;
55: 490–501.
27.
SpielmannKKayserABeckEet al.
Pregnancy outcome after anti-migraine triptan use: a prospective observational cohort study. Cephalalgia2017: 333102417724152.
28.
WoodMELapaneKFrazierJAet al.
Prenatal triptan exposure and internalising and externalising behaviour problems in 3-year-old children: results from the Norwegian Mother and Child Cohort Study. Paediatr Perinat Epidemiol2016;
30: 190–200.
29.
AmundsenSNordengHNezvalova-HenriksenKet al.
Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat Rev Neurol2015;
11: 209–219.
30.
PasternakBSvanstromHMolgaard-NielsenDet al.
Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA2013;
310: 1601–1611.
31.
ChoiJSHanJYAhnHKet al.
Fetal and neonatal outcomes in women taking domperidone during pregnancy. J Obstet Gynaecol2013;
33: 160–162.
32.
Administration UFaD. FDA Drug Safety Communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. 2011. Available at: https://www.fda.gov/drugs/drugsafety/ucm243903.htm#sa
33.
AfridiSKShieldsKGBholaRet al.
Greater occipital nerve injection in primary headache syndromes–prolonged effects from a single injection. Pain2006;
122: 126–129.
34.
GovindappagariSGrossmanTBDayalAKet al.
Peripheral nerve blocks in the treatment of migraine in pregnancy. Obstet Gynecol2014;
124: 1169–1174.
35.
KallenB.Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med2004;
158: 312–316.
36.
RobinsonAYGroganPM.OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report. Mil Med2014;
179: e703–e704.
37.
YokoyamaKTakahashiNYadaYet al.
Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev2010;
86: 187–191.
38.
TeranEHernandezINietoBet al.
Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet2009;
105: 43–45.
KauppilaAArvelaPKoivistoMet al.
Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol1983;
25: 819–823.
46.
BholaRKinsellaEGiffinNet al.
Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain2015;
16: 535.
47.
GoadsbyPJReuterUHallstromYet al.
A Controlled trial of erenumab for episodic migraine. N Engl J Med2017;
377: 2123–2132.
48.
SilbersteinSDDodickDWBigalMEet al.
Fremanezumab for the Preventive treatment of chronic migraine. N Engl J Med2017;
377: 2113–2122.
49.
RaffaelliBIsraelHNeebLet al.
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opin Pharmacother2017;
18: 1409–1415.
